• Nenhum resultado encontrado

VEZT, a novel putative tumor suppressor, suppresses the growth and tumorigenicity of gastric cancer.

N/A
N/A
Protected

Academic year: 2017

Share "VEZT, a novel putative tumor suppressor, suppresses the growth and tumorigenicity of gastric cancer."

Copied!
14
0
0

Texto

Loading

Imagem

Table  1.  Relationship  between  VEZT  expression  levels  in cancer  tissues  and  clinicopathological  factors  in  patients with gastric cancer.
Figure 1.  Methylation analysis of normal gastric tissues, primary gastric cancer tissues and peripheral blood from gastric carcinoma patients and healthy controls
Figure  2.    Helicobacter  pylori  infection  promotes  the  methylation  and  silencing  of  VEZT
Figure 3.  Function of VEZT in gastric cancer cells.  (A) The different expression levels of VEZT in five gastric cancer cell lines and one immortalized gastric mucosal cell line
+2

Referências

Documentos relacionados

Promoter polymorphisms and methylation of E-cadherin (CDH1) and KIT in gastric cancer patients from northern Brazil. Role of c-Src activity in the regulation of

Effect of Tα1 on IL-6 cytokine secretion in PBMCs from healthy donors (HD) and gastric cancer patients (GCa), and in TILs from gastric cancer patients.. The levels of Th2

In this study, we identi fi ed the higher expression of lncRNA ANRIL in gastric cancer tissues than in corresponding non-tumor tissues, and it was also up-regulated in MKN-45

Consistent with the result that p21 protein was down-regulated in the gastric cancer tissues [23], we observed that HDAC4 promotes gastric cancer cell proliferation and growth,

To determine whether genetic susceptibility to noncardia gastric cancer was present, the association between IL10 variants and the risk of noncardia gastric cancer stratified

METHOD : Loss of heterozygosity of the p53, APC, DCC and Rb genes was studied in 22 gastric cancer tissues using polymerase chain reaction; single-strand conformation polymorphism

A recent randomized controlled trial from Japan showed that eradication of H pylori in patients undergoing endoscopic resection for early gastric cancer, followed for 3 years,

In the past the Japanese Society of Gastric Cancer de- ined the following criteria for endoscopic resection (4, 8, 13) of gastric cancer based on results for endoscopic treatment